Metabolix, Inc.
21 Erie Street
Cambridge,
MA 02139
United States - Map
Phone: 617-583-1700
Fax: 617-583-1768
Web Site: http://www.metabolix.com
| Metabolix, Inc., a bioscience company, develops and commercializes alternatives to petrochemical-based plastics, chemicals, and energy. It applies metabolic engineering and molecular biology tools to produce biobased plastic in microbial systems and directly in non-food plant crops. The company offers its proprietary microbial fermentation system to produce a family of polymers known as polyhydroxyalkanoates under the Mirel name. Mirel is used for injection molding, cast sheet, cast and blown film applications, and thermoforming. It sells these bioplastic alternatives to petroleum-based plastics for use in a range of commercial applications, including products used in agriculture and horticulture, compost and organic waste diversion bags, marine and aquatic applications, consumer products, business equipment and durable goods, and general packaging materials. In addition, the company is also developing a proprietary platform technology for co-producing plastics, chemicals, and energy from crops, such as switchgrass, oilseeds, and sugarcane. It has a strategic alliance with ADM Polymer Corporation. The company was founded in 1992 and is headquartered in Cambridge, Massachusetts. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Richard P. Eno , 48
Chief Exec. Officer, Pres and Exec. Director |
$
413.00K |
$
0 | Dr. Anthony J. Sinskey , 69
Co-Founder, Director, Chairman of Compensation Committee and Member of Nominating & Corp. Governance Committee |
$
45.00K | N/A | Mr. Joseph D. Hill , 46
Chief Financial Officer, Principal Accounting Officer and Treasurer |
$
296.00K |
$
0 | Dr. Oliver P. Peoples Ph.D., 50
Chief Scientific Officer, VP of R&D |
$
413.00K |
$
372.00K | Ms. Sarah P. Cecil , 57
Sec. and Gen. Counsel |
$
310.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.29% Nasdaq 
Profile
